China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study in reprogram of RBC paracrine signaling in type 2 diabetes leading cardiovascular injury'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130780
Registration Time: 2026/08/24
Type: Observational study
Primary Sponsor: Yongchuan Hospital of Chongqing Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330995
Published by HT Digital Content Services with permission from Health Daily Digest....